-
To ling pharmaceutical industry won the "2020 Chinese medicine heritage innovation enterprise"
Time of Update: 2021-02-24
According to the introduction, under the background of the vigorous promotion of national policies, Toling Pharmaceuticals will further develop its research and development and production advantages, pass on the essence, keep positive innovation, promote the revitalization and development of Chinese medicine, accelerate the modernization, industrialization and internationalization of Chinese medicine, and contribute to the development of Chinese medicine.
-
The chairman of China Pharmaceuticals, a well-known pharmaceutical company, resigned
Time of Update: 2021-02-11
Pharma.com February 4 - China Pharmaceuticals Chairman resigns Feb. 3, one of the three major state-owned enterprises with the pharmaceutical industry as its main business, China Pharmaceuticals announced that Chairman Gao Yuwen, due to work adjustment reasons, applied to resign as chairman of the company (legal representative), director and the board of directors of the relevant positions of the special committee.
-
40% of Sanofi's market is in a hurry? Sichuan pharmaceutical companies have entered the market with more than 1 billion anti-epileptic injections
Time of Update: 2021-02-11
source: MED2.0 China Drug Review Database Prior to this, sodium valium val has been injected with a strong solution in Chengdu Lil Pharmaceuticals to copy 3 categories of applications submitted for listing in the review and approval (in the drug review center).
-
Ering Pharmaceuticals: Let the party flag fly high on the front line of supply protection
Time of Update: 2021-02-10
Medical network February 5, "epidemic prevention and control, everyone has to make their own contribution, not to mention our husband and wife are both party members, this time not on when." " in the Ridge pharmaceutical preparations a workshop, even flowering plague capsule production site is busy.
-
Hesco will take $2.8 billion
Time of Update: 2021-02-04
Truvada Global Sales (millions of dollars) Source: Milnet Multinational Listed Companies Sales Database Entrutha Binte Nofovir Tablets, originally developed by Gilead's Truvada, was approved by the FDA in August 2004 for the treatment of HIV-1 infection in a joint antiretroviral drug, and in 2012 was approved by the FDA for adults with HIV-1 infection resulting from sexual transmission, the world's first HIV prevention drug.
-
Koren added another imitation! 10 intestinal nutrition drugs
Time of Update: 2021-02-02
Pharmaceutical Network February 1st, January 29th, NMPA official website shows that Colum Pharmaceuticals' compound amino acid (15AA-I)/glucose electrolyte injection, omega-3 fish oil/long-chain fat emulsion injection was approved for the market.
compound amino acid (15AA-I)/glucose electrolyte injection for the domestic first imitation, omega-3 fish oil / long-chain fat emulsion for the second domestic.
-
Beda Pharmaceuticals to issue "H shares"
Time of Update: 2021-02-01
A few days ago, Beda Pharmaceuticals announced that the company has considered the adoption of the "on the company's H-share issue and listing on the main board of the Stock Exchange of Hong Kong Lim
-
Dongsong medicine and a new class of drugs hit the impact of a surge of 900% insulin
Time of Update: 2021-01-30
source: CDE official heC88473 injection is the first new class 1 drug to submit a clinical application in 2021; Degu insulin injection is a new, ultra-long-effect insulin analogue,2 Global sales exceeded US$1.5 billion in 2019, and in the first half of 2020, terminal sales of urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) exceeded 50 million, up 922.6% YoY.
-
Well-known pharmaceutical companies to abolish the sales team
Time of Update: 2021-01-30
Mharma representatives how to deal with the professional test of the above-mentioned people to SaibaiLan said that the reason why more and more pharmaceutical companies began to choose to give varieties to agents to do, mainly because a team of agents can operate multiple varieties at the same time, can accept the situation of profit compression, compared to the enterprise self-built sales team, the cost is relatively small.
-
Hunan pharmaceutical companies took more than 8 billion oral anti-sugar drugs, the original research drugs were again affected
Time of Update: 2021-01-30
Medicine Network January 22 - January 21, the Official Website of the State Drug Administration shows that Hunan Qianjin Xiangjiang Pharmaceutical's Akapo sugar tablets to copy 4 categories of products were approved, and as reviewed.
-
Charles River Laboratory has collaborated with Driv Bio to expand biology
Time of Update: 2021-01-25
And Charles River will rely on its industry-leading service strategy and regulatory expertise to help us better serve and support a growing number of businesses locally and globally." - Dr. Claudia Lin, founder and CEO of Drive Jade Bio, about Charles River Charles River providing pharmaceutical and biotechnology companies around the world with the necessary products and services to accelerate their drug research and development efforts.
-
CRO track all-line surge Tag Pharmaceuticals, Kanglong into a 10% rise in the rise and stop of new drugs
Time of Update: 2021-01-25
CRO enterprises are divided into preclinical CRO and clinical trial CRO two major categories, the current preclinical CRO is mainly engaged in compound research services and preclinical research services, including research, pilot compounds and active drug intermediate synthesis and process development, domestic and foreign companies are mainly Charles River, Covance (has been acquired by LabCorp), Syneos, Pharmaceutical Mingkangde (Apptec), Zhao yanxin pharmaceutical (Joinn Lab), Kanglong.
-
The Roche Tecentriq/Avastin combination improves the overall survival of hepatocellular carcinoma
Time of Update: 2021-01-25
In response, Levi Garraway, Roche's chief medical officer and head of global product development, said the results showed that Tecentriq and Avastin's Phase III trial results showed that patients reached the longest survival rate in non-removable hepatocellular carcinoma first-line treatment, a combination that has now been approved by regulators in more than 60 countries and regions around the world, meaning the combination has helped make significant progress in treating this malignant tumor.
-
The application for clinical trial of the MCLA-129 injectable drug from Beda Pharmaceuticals was accepted
Time of Update: 2021-01-25
MCLA-129 is expected to effectively address EGFR inhibitor resistance caused by a variety of mechanisms, especially c-Met amplification or over-expression, with the potential to provide benefits to patients with drug-resistant NSCLC.
-
What's so special about the layout of the research and development pipeline for the old drivers of pharmaceutical companies?
Time of Update: 2021-01-25
Romosozumab Drug Overview Source: Pharmaceutical Intelligence Data Pipeline Source: Amjin's official website Romosozumab currently has four listings, 82 clinical trials, eight of which were released in the last year, and the drug's sales figures for 2019 are 238.257 million yuan.
-
Hepple intends to transfer Kymab's stake, which was acquired by Sanofi
Time of Update: 2021-01-25
FP BV, a wholly owned subsidiary of Sanofi, signed an equity transfer agreement with all Kymab shareholders, including Hong Kong-based Hepple, to take a full stake in Kymab.
2017, Hong Kong-based Heppry acquired Kymab's 8,487,385 C-Series Preferred Shares for $36.5 million.
-
To Ling Pharmaceutical Lianhua Qing plague capsules to obtain the Mongolian drug registration approval
Time of Update: 2021-01-25
announcement, Lianhua Qing plague products have been repeatedly included in the National Health And Health Commission, the State Administration of Traditional Chinese Medicine cold, influenza-related disease diagnosis and treatment program.
-
3.5 billion injection varieties Hengrui will take the first imitation
Time of Update: 2021-01-24
4 enterprises, such as Hengrui Pharmaceuticals, Colum Pharmaceuticals, Vit Pharmaceuticals and Yangzijiang Pharmaceutical Group, submitted applications for the listing of sodium chloride injections of right metomide hydrochloride according to the imitation 3 categories.
-
Micro-invased medical split, the latest news announced
Time of Update: 2021-01-24
Pharmaceutical Network January 14 - Micro-invased medical robots to be listed January 12, according to China Electronic News, Shanghai minimally invascope medical robots (Group) Co., Ltd. has signed a listing counseling agreement with COFCO, the proposed listing of the board.
-
Anhui Hongye Pharmaceutical Co., D.C. Lekadi tablets were approved for the birth of the 3rd domestic
Time of Update: 2021-01-23
Pharmaceutical Network January 20, January 18, NMPA official website shows that Anhui Hongye Pharmaceuticals according to the imitation of the 4 categories of reported production of hydrochloric acid Lekadi flat tablets were approved and treated as a review, becoming the third domestic.
